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Introduction
Non-communicable diseases (NCDs) are the major threats to public health and economic growth in developed and 
most developing countries.1 NCDs, especially cardiovas-
cular diseases (CVD), cancers, chronic respiratory diseases, and 
diabetes were responsible for 63 % of all deaths in 2008 world-
wide, with higher proportion in low- and middle-income coun-
tries.2  By 2020, these diseases will have caused seven out of every 
ten deaths in developing countries.3 CVDs have been a leading 
cause of death in Iran, responsible for 47 % of all deaths in 1995 
compared with 27 % in 1981.4
NCDs share common risk factors, such as unhealthy diet, physi-
cal inactivity, tobacco use and harmful alcohol consumption, 
which are amenable to intervention.5 By eliminating these major 
risk factors 80 % of heart diseases, strokes, and type 2 diabetes, 
and over 40 % of cancers could be avoided.6 According to esti-
mates by WHO, in the absence of preventative measures the num-
ber of deaths caused by NCDs will increase by 17 % on a global 
scale over the next 10 years.1 The aforementioned behaviors lead 
to metabolic/physiological changes such as raised blood pressure, 
overweight/obesity, hyperglycemia and hyperlipidemia.
It was estimated that 13 % of global deaths are attributed to high 
blood pressure, 9 % to tobacco use, 6 % to high blood glucose, 6 
% to physical inactivity, and 5 % to overweight and obesity.7 In 
Global Burden of Disease (GBD) study 2010, dietary risk factors 
and physical inactivity collectively accounted for 10.0 % of global 
DALYs, with the most prominent dietary risks being diets low in 
fruits and those high in sodium. In addition, the second leading 
risk factor was tobacco smoking including second-hand smoke 
(6.3 % of global DALYs).8 +RZHYHUWKH¿YHOHDGLQJULVNIDFWRUV
of disease burden among Iranian population are dietary risks, high 
blood pressure, high body-mass index, physical inactivity, and 
smoking, respectively.9
Non-optimal nutrition is a risk factor with several elements. As 
a result, it is impossible to align varying sources and types of data 
to generate an overall estimation of unhealthy diet prevalence.10 
It is estimated that up to 2.635 million deaths per year worldwide 
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are attributable to low fruit and vegetable consumption. Increas-
ing fruit and vegetable intake up to 600 g per day could reduce 
the total global burden of disease by 1.8 % and reduce the burden 
of ischemic heart disease and ischemic stroke by 31 % and 19 
%, respectively.11 Similarly, high salt intake is an important deter-
minant of high blood pressure levels and overall cardiovascular 
risk.12 It is estimated that decreasing dietary salt intake from the 
current global levels of 9 – 12 grams per day to the recommended 
level of 5 grams per day will have a major impact on reducing 
the risk.13 High consumption of saturated fat and trans-fatty ac-
ids are other unhealthy behaviors linked to heart disease and type 
2 diabetes,14,15 replacement of which with monounsaturated and 
polyunsaturated fat reduces the risk.16
Physical inactivity, the fourth leading risk factor for death in 
global scale, is responsible for around 3.2 million deaths per year.7 
This risk factor can account for 22% of ischemic heart disease, 
11% of ischemic stroke, 14% of type 2 diabetes, 16% of colon 
cancer, and 10% of breast cancer.17,QVXI¿FLHQWSK\VLFDODFWLYLW\
is more prevalent in high-income countries, but currently it goes 
also to be common in some middle-income countries.18 Results of 
national surveys show that more than 80% of Iranian population 
are physically inactive.19
Tobacco smoking is the single greatest preventable cause of 
death in the world.20 Almost 6 million people die from tobacco 
use each year, of which, just over 600,000 are attributable to sec-
ond-hand smoke exposure, and more than 5 million are due to 
direct tobacco use. Most of these deaths occur in low- and middle-
income countrie.21 In Iran, smoking was responsible for 11,000 
deaths in 2005.22 Nowadays, about 82 % of 1.1 billion smokers in 
the world reside in low- and middle-income countries.23 Recent 
data in Iran shows 62 % increase in cigarette production from the 
period of 2000-2004 to 2005 – 2009.24 National surveys have in-
dicated that 14.6 %, 15.3 % and 11.7 % of Iranian population are 
smoker.25–27
Trend analysis of the attributed adverse health effects of non-
optimal nutrition, physical inactivity, tobacco smoking among 
Iranian population at national and sub-national levels is a sub-
component of National and Sub-national Burden of Diseases, In-
juries, and Risk Factors study from 1990 to 2013 in Iran.28 To the 
EHVWNQRZOHGJHRIWKHDXWKRUVRIWKLVDUWLFOHWKLVLVWKH¿UVWVWXG\
which aims to quantify the trends of exposures to lifestyle risk 
factors and their inequalities and attributed burden at national and 
VXEQDWLRQDO OHYHOV7KHDLPRI WKLVDUWLFOH LV WRSURYLGHGH¿QL-
tions, data gathering and generating processes and methodology, 
and statistical methods which will be used in this study.
Methods and Materials
The study is a part of National and Sub-national Burden of Dis-
ease (NASBOD) study which will be conducted by Non-Com-
municable Diseases Research Center (NCDRC), Tehran Univer-
sity of Medical Sciences (TUMS). The technical team includes 
epidemiologists, nutritionists, and public health researchers from 
TUMS, University of California, Los Angeles (UCLA), Munich 
University, and Harvard School of Public Health (HSPH).
Selection of risk factors
Lifestyle risk factors were selected through some expert panel 
meetings, review of Global Burden of Disease and Risk Factor 
study, and global evidences on the effect size of each lifestyle risk 
factor exposure.8,17,29–31 Nutritional risk factors, physical inactivity, 
and smoking were included in the study. To estimate burden of 
non-optimal nutrition, we based our framework on GDB Nutri-
tion and Chronic Disease Expert Group 2010.32 The reason behind 
such selection is the similarity between framework (comparative 
risk assessment) and objective of study (assess the impact of sub-
optimal nutrition on CVD, diabetes and cancer). However, there 
are some minor differences between our approach and the afore-
mentioned study. After consultation with key informants and also 
based on the evidence provided by other researchers we included 
³¿VK´ DV DQ LQGHSHQGHQW IRRG JURXS33 In addition, the “dairy 
group” was included instead of “milk” which was used in GBD.
'H¿QLWLRQVRIOLIHVW\OHULVNIDFWRUVRILQWHUHVW
To facilitate comparability across regions, time periods and each 
risk factor assessment methods, we created standardized optimal 
H[SRVXUH GH¿QLWLRQV DQG XQLWV RI PHDVXUH IRU HDFK ULVN IDFWRU
(Table 1). We selected these units of measure to be 1) as similar 
as possible to the corresponding values in epidemiological studies 
or trials used to quantify the harmful or protective effects of each 
risk factor on major NCDs such as CVD, diabetes and cancer risk; 
2) most interpretable from biologic and policy perspectives when 
considering diet, physical activity and smoking, and 3) as similar 
DVSRVVLEOHWRFRPPRQGH¿QLWLRQVXVHGWRDVFHUWDLQH[SRVXUHGDWD
in Iran.
7KHSUDFWLFDOGH¿QLWLRQVRIULVNIDFWRUVH[SRVXUHVZHUHIRUPHG
based on the availability of data, methodology, and the effect size 
of risk factors in different levels of exposures (Table 1). Practical 
GH¿QLWLRQRIQRQRSWLPDOQXWULWLRQLVEDVHGRQ0LFKDHWDOVWXG\32
Research objectives
The objective of this study is to determine the prevalence and 
trends of lifestyle risk factors exposure for each year, sex, age, and 
province from 1990 to 2013 among Iranian population at national 
and sub-national levels. Moreover, attributed burden of diseases 
will be estimated for selected lifestyle risk factors exposures, as 
well as attributed deaths and disability-adjusted life years (DALY) 
for the same period of time in Iran. Finally, socioeconomic and 
geographical distribution of risk factors exposures and their deter-
minants will be evaluated.  
Data sources and retrieval
Systematic searches and reviews will be performed to identify 
representative studies to extract mean and standard deviation of 
lifestyle risk factors exposures or reported prevalence based on 
WLPHSHULRGV VH[DQGDJHVSHFL¿FJURXSV6WDQGDUGL]HGSURWR-
cols have been developed to allow collection, analysis and extrac-
tion of data in a systematic and consistent manner which includes 
VWDQGDUGL]HGV\VWHPDWLFOLWHUDWXUHVHDUFKHVLGHQWL¿FDWLRQDQGLQ-
clusion of relevant surveys, survey quality assessment and data 
extraction.
Systematic Literature Review
We will search for nationally representative surveys which have 
provided exposure data on the lifestyle risk factors of interest. 
0XOWLSOHVRXUFHVKDYHEHHQVHOHFWHGWKURXJKWKHVFLHQWL¿FSDQHO
LQFOXGLQJ3XE0HG0('/,1(,QVWLWXWHRI6FLHQWL¿F,QIRUPDWLRQ
(ISI), and Scopus as international electronic databases, as well as 
,UDQLDQGDWDEDVHVVXFKDV,UDQ0HGH[,UDQGRFDQG6FLHQWL¿F,Q-
formation Database (SID) as comprehensive national electronic 
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databases. In addition, hand searching of unpublished databases 
such as government reports, projects reports, conference presen-
WDWLRQVDQGUHIHUHQFHOLVWVRILGHQWL¿HGVWXGLHVDQGGLUHFWFRQWDFW
with authors will be used to identify relevant population-based 
studies performed between 1990 and 2013. The search will be 
limited to human studies conducted in Iran with no language re-
striction. 
The search through international databases will be performed 
using MeSH terms, Entry terms, Emtree, and related key words. 
Persian key words will be mostly developed based on their Eng-
lish equivalents, and some expert panels will be also conducted to 
review any probable key word with no English equivalent. Search 
terms are presented in Appendix in detail.
Selection criteria
We will include cross-sectional studies which include the fol-
lowings: representative sample size, results of baseline surveys 
of population-based cohort studies, control groups in case control 
studies (if they are selected from general population), and base-
line data from community-based trials. The study will be included 
only if it is reasonably population-based and representative, and 
exposure data has been reported or could be plausibly obtained 
IURPWKHVWXG\)RUULVNIDFWRUVZLWKQRVXUYH\VLGHQWL¿HGRWKHU
sources of potential data will be considered.
Moreover, all national, provincial, district and community stud-
ies which have reported prevalence of food/nutrient, physical in-
activity, and smoking exposures among their general population 
will be included. The target population is healthy Iranian adult 
population living in Iran from 1990 to 2013.
Case reports, case series, clinical trials with small sample size, 
and also non population-based surveys will be excluded. Further-
more, studies with no report on the sampling method or studies in 
Risk Factor 'H¿QLWLRQ Optimal unit of measure
Components of non-optimal 
nutrition†
Fruit Total fruit intake g/day (ideally energy adjusted)
Fruit Juice Total fruit juices intake g/day (ideally energy adjusted)
Vegetable Total vegetable intake Exclude salted or pickled vegetables, vegetable juices, starchy vegetables g/day (ideally energy adjusted)
Beans, legumes Total intake of beans and legumes,Including tofu, excluding soy milk g/day (ideally energy adjusted)
Nuts, seeds Total intake of nuts and seeds g/day (ideally energy adjusted)
Whole grain Total intake of whole grain foods g/day (ideally energy adjusted)
Red meat Total red meat intake g/day (ideally energy adjusted)
Processed meat
Total processed meat intake (for example, processed deli or luncheon 
meats (ham, turkey, pastrami, etc.), bacon, salami, sausages, bratwursts, 
frankfurters, hotdogs)
g/day (ideally energy adjusted)
Milk Total milk intake (combined non-fat, low-fat and full-fat milk). g/day (ideally energy adjusted)
Sugar-sweetened beverages
7RWDOVXJDUVZHHWHQHGEHYHUDJHVLQWDNHGH¿QHGDVDQ\VXJDUVZHHWHQHG
EHYHUDJHZLWK;NFDOSHUR]JVHUYLQJLQFOXGLQJFDUERQDWHG
beverages, soft drinks, sodas, energy drinks, fruit drinks
g/day (ideally energy adjusted)
Saturated fat Total saturated fat intake from all dietary sources g/day (ideally energy adjusted)
Omega-6 polyunsaturated fat Total omega-6 fatty acid intake from all dietary sources g/day (ideally energy adjusted)
Seafood omega-3 fat Total dietary EPA&DHA (eicosapentaenoic, docosahexaenoic) intake mg/day (ideally energy adjusted)
Plant omega-3 fat 7RWDOGLHWDU\$/$ĮOLQROHQLFDFLGLQWDNH mg/day (ideally energy adjusted)
Trans fatty acid Total trans fatty acid intake from all dietary sources % kcal (energy contribution)
Dietary cholesterol Total dietary cholesterol from all dietary sources mg/day (ideally energy adjusted)
'LHWDU\¿EHU 7RWDOGLHWDU\¿EHULQWDNHIURPDOOGLHWDU\VRXUFHV g/day (ideally energy adjusted)
Dietary sodium Total dietary sodium intake from all dietary mg/day (ideally energy adjusted)
Dietary calcium Total dietary sodium intake from all dietary mg/day (ideally energy adjusted)
Components of Physical 
Inactivity
3K\VLFDOLQDFWLYLW\LVDFWLYLW\OHYHOLQVXI¿FLHQWWRPHHWSUHVHQW
recommendations‡.
Components of Smoking Tobacco smoking including second-hand smoke, Tobacco smoking excluding second-hand smoke, second-hand smoke
Tobacco smoking
Type of smoking: Tobacco smoking (cigarette, hooka, pipe, chopogh) 
Duration of smoking: Ever smoked, Past smoked, Current smoked (Daily 
or Occasionally) Severity of smoking: Mild, Moderate, Heavy smoker 
Second-hand smoke Exposure to second-hand smoke from several sources, including parents, siblings, spouses, co-workers, and from persons in public settings.
†components of non-optimal nutrition based on framework suggested in Micah et al study
‡Physical activity recommendation (adults 18 – 64 year old): 
1- Accumulate at  least 150 minutes of moderate-intensity  aerobic physical activity throughout the  week or do at least 75 minutes of vigorous intensity 
aerobic physical activity  throughout the week or an equivalent  combination of moderate- and vigorous intensity activity
2- Aerobic activity should be performed in  bouts of at least 10 minutes duration
 )RUDGGLWLRQDOKHDOWKEHQH¿WVDGXOWVVKRXOGLQFUHDVHWKHLUPRGHUDWHLQWHQVLW\DHURELFSK\VLFDODFWLYLW\WRPLQXWHVSHUZHHNRUHQJDJHLQ
minutes of  vigorous-intensity aerobic physical activity  per week, or an equivalent combination of  moderate- and vigorous-intensity activity
Table 1. 3UDFWLFDO'H¿QLWLRQRI/LIHVW\OH5LVN)DFWRUV
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which participants had been selected via non-random sampling 
methods will be excluded. Population-based studies which had 
included the following groups will be excluded: 1) Unhealthy 
populations such as patients in a hospital or a clinic; 2) Those with 
special physiological conditions such as pregnant and lactating 
PRWKHUV VSHFL¿FSRSXODWLRQJURXSVEDVHGRQ WKHLU XQ HP-
ployment, occupation or education status (e.g. doctors or univer-
sity students); 4) immigrants.
Process of Study Selection
6WXG\VHOHFWLRQZLOOEHSHUIRUPHG LQ WKUHHSKDVHV ,Q WKH¿UVW
step, the reviewer will scan titles according to the selection cri-
teria. The accepted titles will be entered into the abstract review 
phase to identify studies for eligibility. In the next phase, abstracts 
will be reviewed and the study will be excluded if the reviewer 
¿QGVWKDWWKHVWXG\PHHWVRQHRUPRUHH[FOXVLRQFULWHULD7KHODVW
phase will be performed independently by two reviewers to deter-
mine if the full texts should be included for data extraction. Dis-
agreements regarding full text article inclusion will be resolved by 
discussion and consensus adjudication or by a third party. 
Other data sources
Other data sources which will be used in this study include na-
tional censuses, national registration systems, and national and 
VXEQDWLRQDO6XUYH\V6H[ DJH DQGSURYLQFH VSHFL¿FGDWDZLOO
be obtained from Iran censuses of 1986, 1996, 2006, and 2011. A 
OLVWRILGHQWL¿HGQDWLRQDODQGVXEQDWLRQDOVXUYH\VDQGUHODWHGULVN
factors exposure (suboptimal nutrition, physical inactivity and 
smoking) are listed in Table 2.
Data extraction
Details from eligible studies will be extracted using a pre-de-
signed data extraction form on Microsoft Excel database. This 
form includes general information and data information (Table 
3). Required data include mean, standard deviation, standard error 
(SE) of mean, and number of observations for each risk factor by 
age, sex, province/district of the country. For the articles without 
mean or standard deviation, we will contact the authors to request 
the related data. If a paper meets the inclusion criteria without re-
porting data based on age and sex, we will contact its author to 
invite them to join the Collaborating Group.
Quality assessment
Article quality will be assessed according to both sampling and 
measurement criteria using an adopted quality assessment form. 
The form has three parts: general information, sampling quality, 
and measurement quality. Each article has a unique code and the 
name and characteristics of the corresponding author will be in-
serted on the top of the form. Other general information of interest 
include study source, study design, scope of study, and level of 
study.
Sampling quality refers to the sample representativeness, re-
sponse rate, sample size, and sampling method. Quality of mea-
surement includes type of measurement tools, calibration of tools 
or validity of methods/questionnaires used for assessing diet, 
physical activity, or smoking. A ranking scale has been developed 
WRDVVHVVWKHTXDOLW\RILGHQWL¿HGVXUYH\VDQGVWXGLHVDQGWKHYD-
lidity of the measurement tools used. Accordingly, each item ob-
tains a score (Table 4), and the quality score will be calculated for 
all included papers.
Statistical methods and analysis plans
Data scarcity will be expected in our work regardless of a com-
prehensive search and access to national surveys. To overcome 
the problem of data gaps in provinces, and in some age or sex 
groups or in urban/rural areas, two distinct statistical models; i.e. 
Spatio-temporal model and multilevel autoregressive model were 
designed. Using these models, mean (whatever measure is) and its 
uncertainty interval by sex, age, year, and province will be esti-
PDWHG,QSXWVIRUWKHPRGHOVZLOOLQFOXGHGDWDRIVSHFL¿FDJHVH[
province or area, as well as data obtained from other ages, other 
years, and other provinces. The problem of misaligned areal units 
will be also addressed in these models. Misalignment means that 
parts of some provinces have been separated in the time period of 
interest. Using both models helps us to make sure that there is no 
model dependency in the results.  
Spatio-temporal Bayesian Hierarchical model   
One of the solutions for the aforementioned statistical issues 
is Spatio-temporal Bayesian hierarchical modeling with condi-
tional autoregressive (CAR) prior for spatial random effects.34 
In spatial modeling, it is assumed that data closer to the space 
will be more correlated than the farther data. This model helps 
to produce individual estimates for areas with missing values or 
in age/sex by “borrowing information” from neighbors of each 
area. Spatio-temporal misalignment modeling will be also applied 
to combine incompatible areal units between data sources and/or 
over the years. In addition, we will employ Spatio-temporal mis-
alignment modeling to combine incompatible areal units between 
data sources and/or over the years. The model includes covari-
ates effects, non-linear age trend, study quality, and source of data 
variations.  
Bayesian Multilevel Autoregressive model
Bayesian multilevel autoregressive model is another method 
to overcome the problem of data scarcity and misalignment.35 In 
this procedure, observations are hierarchically nested in districts, 
provinces, sub-regions, regions, and national levels respectively. 
In this hierarchical model, higher levels borrow information to the 
lower levels and units of each level borrow information to each 
other depending on the degree of data availability. The model con-
siders several different components including linear time trends, 
nonlinear change over time, covariate effects, nonlinearity associ-
ated with age, heterogeneity of data sources, and age variability 
among studies. Time-varying covariates at the district- level or 
province-level covariates inform the estimates if practical.
In both modeling framework, the MCMC methods will be used 
for their general applicability and ease of implementation to per-
form Bayesian inference. All programs will be written in R statis-
tical packages (version 3.0.1).
The other statistical issue in this study is summary statistics 
ZKLFKKDYHEHHQUHSRUWHGLQGLIIHUHQWFODVVL¿FDWLRQ:HZLOOGR
cross walk between continuous and categorical measures of vari-
ables using regression models. 
Discussion
In the current study, burden of major NCDs attributable to life-
style risk factors will be assessed at national and sub-national 
levels in Iran between 1990 and 2013. Most studies of disease, 
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Survey and abbreviation            Year Survey Explanation Risk Factor exposure
Non-Communicable Disease 
Surveillance Survey (NCDSS)
First Survey: 2005
Second Survey: 2006
Third Survey: 2007
Fourth Survey: 2008
Fifth Survey: 2009
Sixth Survey: 2011
NCDSS was surveillance of risk factors for non-communicable 
disease conducted based on World Health Organization (WHO) 
STEPwise approach in 6 different years at provincial and sub 
provincial levels. The study sample was representative subjects aged 
15-65 years, selected via multistage cluster sampling method from 
urban and rural population of all provinces in Iran.
|Smoking
|Physical 
Activity
|Nutrition  
National Health Survey (NHS) 1989, 1999
This survey was designed to gain comprehensive knowledge and 
LQIRUPDWLRQDERXWKHDOWKFDUHSUREOHPVDQGGLI¿FXOWLHVWKURXJKRXWLQ
Iran. It combined home interview and health examinations which are 
performed by trained personnel. The survey repeats each ten years 
and so far, the result of two surveys has been published. One of the 
major aims of the survey is to assess risk factors and indicators of 
health and illness in Iranian population.
|Smoking
|Physical 
Activity
|Nutrition
Isfahan Healthy Heart 
Program(IHHP)
Phase I: 2000–2001
Phase II:2001–2005
Phase III: 2006–2007
IHHP is a longitudinal study aimed to control CVD risk factors and 
to reduce CVD related morbidity and mortality in Isfahan Province, 
a central region in Iran. It comprisedof 3-phase study of situation 
analysis, integrated community-based interventions, and outcome 
evaluation. Phase I was situation analysis which provided data on 
basic characteristics of Isfahan, Najaf-Abad and Arak residents. 
Phase II was a community- based, action-oriented intervention 
program. Isfahan and Najaf-Abad were two intervention sites 
whereas Arak was the control site. Phase III was an evaluation study 
to see whether such interventions has been successful in reaching its 
goals. 
|Smoking
|Physical 
Activity
|Nutrition
Tehran Lipid and Glucose Study 
(TLGS)
Phase I: 1999–2000
Phase II: follow up, 
every three years
TLGS is a cohort longitudinal study aimed to prevent NCD by 
development of a healthy lifestyle and reduction of NCD risk 
factors in an urban district (district 13) of Tehran. In Phase I, 15005 
participants over 3 years of age were selected by multistage cluster 
random sampling and provided baseline information on NCD 
prevalence and associated risk factors. Phase II was a follow up study 
in which lifestyle interventions were implemented in 5630 people 
and 9375 individuals served as controls, and NCD risk factors were 
evaluated. Collection of data will be repeated every 3 years to assess 
the effects of different interventions in the intervention group as 
compared to control group. The study begun in 1999, is ongoing, to 
be continued for at least 20 years.
|Smoking
|Physical 
Activity
|Nutrition
Golestan Cohort Study (GCS) 2004–2012
he study is an ongoing population-based cohort to identify risk 
factors for Oesophageal Cancer in Golestan Province, located in 
North-East of Iran.  It provided baseline information on 50000 
healthy individuals who were enrolled between January 2004 and 
June 2008 and were followed to May 2011. The participants are being 
followed up actively every 12 months and the follow-up is expected 
to continue for a minimum of 10 years.
|Smoking
|Physical 
Activity
|Nutrition
Persian Gulf Healthy Heart 
Study (PGHHS)
Phase I: 2003–2004
Phase II: follow up 
-continued
It is a ten year longitudinal study to establish healthy lifestyle in 
Northern Persian Gulf Area. Phase I was a cross-sectional prevalence 
study which used a multi-stage cluster sampling to provide a 
baseline survey on unhealthy lifestyles and CVD risk factors. Phase 
II comprised a multiple intervention project aimed to reduce CVD 
through several interventional studies at the community level. For 
program evaluation, WHO MONICA protocol was used to report 
daily coronary artery risk factors, morbidity and mortality of 
coronary artery disease as well as stroke.
|Smoking
|Physical 
Activity
|Nutrition
Iranian Multicenter 
Osteoporosis Study(IMOS) 2000, 2011
The aim of this cross-sectional study was to establish reference 
values for Bone Mineral Density among Iranian population. It 
also aimedto provide information regarding the current calcium 
and vitamin D status in target population. In 2000 the study was 
FRQGXFWHGLQ¿YHFLWLHVLQFOXGLQJ7HKUDQ7DEUL]0DVKKDG6KLUD]
and Bushehr, and in 2011 just in two cities, Arak and Sanandaj. 
|Smoking
|Physical 
Activity
Table 2. ,GHQWL¿HGVXUYH\VIURPWRDPRQJ,UDQLDQ3RSXODWLRQ
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injuries and risk factor burden have been at the national or global 
scale.8,32,36–41 However, there are a few sub-national analyses of 
the burden of disease,42,43 as well as some sub-national analyses 
of mortality.44,45
Selected lifestyle risk factors for the underlying NCDs in this 
study include non-optimal nutrition, physical inactivity, and 
smoking which are targeted as the leading risk factors for most 
disease burden in GBD 2010,8 as well as in many other burden 
studies. In  GBD study 1997, attributable burden to each of the 
10 major risk factors were made by specialists on each topic: to-
bacco, alcohol, illicit drugs, occupation, air pollution, poor water 
supply, sanitation, and personal and domestic hygiene, hyperten-
sion, physical inactivity, malnutrition, and unsafe sex.40
In Mexico and its states, deaths and DALYs were estimated 
in 2004 from a comprehensive list of diseases and injuries and 
from 16 risk factors. Selected lifestyle risk factors included to-
bacco smoking, low fruit and vegetable intake, physical inactiv-
ity, alcohol use, and unsafe sex.42 Differences in health levels and 
health determinants across three epidemiological sub regions of 
WHO region for Europe was summarized using the results of the 
GBD 2000 and the associated CRA (Comparative Risk Assess-
ment) project. In that study, 10 risk factors were evaluated includ-
ing: High blood pressure, tobacco, alcohol, high cholesterol, high 
body mass index, low fruit and vegetable intake, physical inactiv-
ity, illicit drugs, lead, and unsafe sex.46
The followings are the strengths and advantages of our study: 
covering major lifestyle risk factors; using different compre-
hensive nationally representative sources of data such as vital 
registration and national censuses, as well as national and sub-
national health surveys and population-based epidemiological 
studies; combining national and sub-national analyses; quantify-
ing uncertainty; applying new statistical models such as Spatio-
temporal Bayesian hierarchical model and Bayesian Multilevel 
$XWRUHJUHVVLYHPRGHOZKLFKDUHGHYHORSHGIRUWKH¿UVWWLPHLQ
Iran to overcome the challenge of low quality of data; determin-
ing inequalities between regions, ages, and sexes, for designing 
HI¿FLHQWKHDOWKSROLFLHVDQGSURJUDPV
Like other population-based studies, our study will have limita-
tions. First of all, because of limited reports of risk factor, some 
important risk factors such as alcohol use, drug abuse, and opium 
use in Iran were not included in this study, since limited reports of 
risk factor–disease relationships is available for them. The estima-
tion of HIV infection that is attributable to unsafe sexual practices 
as well as other sexually transmitted infections will be reported 
in another study.47 The second limitation of this study was the 
currently constructed CRA model which does not fully capture 
all relevant dimensions of exposure. For example, the study es-
timates the burden of disease associated with each risk factor 
separately, acting in isolation from other risk factors. Only very 
approximate estimates of the joint effects of risk factors acting 
together will be provided.
Third, data of relative risks (RRs) will be obtained from large 
international meta-analyses, as the Inter-heart study shows that 
these RRs are consistent across countries after accounting for 
study design and methodological differences.48 Fourth, we will 
use disability weights from global studies, and they are not cal-
Household Expenditure (HHE) 1984–2011
It is a time series study which provides annual information on 
nationwide market value of Iranian Good Basket at household level. 
The Iranian Good Basket consists of “edible as well as tobacco” and 
“nonedible”.
It is a proxy ofnationwide food group intake since it provides 
information on amount of food bought by each household in the 
previous month/week/day.
|Smoking
|Nutrition
Childhood & Adolescence 
Surveillance and Prevention 
of Adult Non-communicable 
disease (CASPIAN Study)
CASPIAN I: 2003–2004
CASPIAN II: 2007–
2008
CASPIAN III: 2009–
2010
CASPIAN IV: 2011–
2012
CASPIAN is a nationwide school-based survey aimedto provide 
information on NCD-related risk behaviors and risk factors in 
childhood and adolescent. It is repeated every two years to update 
information on risk factors. Questionnaires are based on WHO 
STEPwise approach to NCD and the WHO Global School Health 
Survey (GSHS).
|Smoking
Multinational Monitoring 
of Trends and Determinants 
in Cardiovascular Diseases 
(MONICA)
2004
The MONICA Project is designed to measure the trends in mortality 
and morbidity from coronary heart disease (CHD) and stroke, and to 
assess the extent to which they are related to changes in known risk 
factors in different populations in 27 countries. The MONICA was a 
cross-sectional study in Tehran. It aimed to determine cardiovascular 
risk factors among adults residing in district 17 of Tehran, Capital of 
Tehran.
|Smoking
|Physical 
Activity
Nutritional Knowledge, Attitude 
and Practice of Rural and 
Urban Iranian Household as 
well as Health Practitioners in 
three provinces (Pilot study) and 
NUTRIKAP Survey
2004, 2012
The pilot cross-sectional study in 2004, aimed to determine 
nutritional knowledge, attitude and practice of Iranian households 
residing inrural and urban areas of Bushehr, Sistan o Baloochestan 
and Golestan Province. The NUTRIKAP survey was a nationwide 
cross-sectional study aimed to determine nutritional knowledge, 
attitude and practice of Iranian households residingin urban and rural 
areas. 
|Nutrition
Comprehensive Project on 
Household Food Pattern and 
Nutritional Status
1999 This nationwide cross-sectional study aimed to determine intake of food groups and nutrients at household level.
|Nutrition
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A: General information
(I) ID
The ID will include an abbreviation for risk factor (for example; smo. for smoking), province code according to standardized coding, and a number for each 
study.
(II) Study name
If the study has a special name, it is written in the “Study name” column.
(III) Citation
The Citation consists of authors’ name, the title of study, journal name, publication year, volume or number of journal and pages.
(IV) Corresponding author ‘s characteristics
7KH)LVWQDPH)DPLO\QDPHDI¿OLDWLRQORFDWLRQDQGFRQWDFWLQIRUPDWLRQRIWKHFRUUHVSRQGLQJDXWKRUWHOHSKRQHID[DQGHPDLODGGUHVVZLOOEHLQVHUWHGLQ
this column.
(V) Article code
For PubMed articles “PMID” and for ISI articles “DOI” will be recorded.
(VI) Publication and Study year
It refers to the year that article has been published, and he year survey has been conducted.
9,,3UDFWLFDOGH¿QLWLRQ
7KHGHVFULSWLRQRIULVNIDFWRUVDFFRUGLQJWRHDFKVXUYH\LVUHFRUGHGDQGWKHDSSURSULDWH¿QDOL]HGGH¿QLWLRQZLOOEHGHWHUPLQHGEDVHGRQGLVFXVVLRQDQG
consensus adjudication.
(VIII) Subgroup
If the study population is categorized by ethnicity, the subgroups are recorded according to a standardized coding.
(VIIII) Study Included/Excluded by, and Study Cross-checked by
The name of people who will include, exclude and cross-check the studies are inserted in this part.
(X) Study source
0. Iranian databases
1. Foreign databases
2. Non-indexed Iranian journals
3. Health surveys
4. Abstract of congress
5. Theses
6. Other un-published reports
(XI)Study design
1. Cross-sectional
2. Case-control
3. Cohort
4. Others
(XII) Scope of study
1. Rural
         2. Urban
         3. Both
(XIII) Level of study
1. National 
2. Provincial
         3. District
4. Community
5. Sub-region (two or more provinces with similar ethnicity and race)
6. Two or more sub-regions
(XIIII) Sample weight (The target group proportionate to Iranpopulation’s sex and age)
0. No 
1. Yes
B: Data information
Age of participants:
Range: ____ - ______ median:_________ 
Sex:
Male
Female
Both
Sample size
The sample size in each sex and age group of the study population.
Point prevalence 
7KHSRLQWHVWLPDWHPHDQ6'6(ORZHUOHYHODQGXSSHUOHYHORIFRQ¿GHQFHLQWHUYDODUHH[WUDFWHGIURPWKHLQFOXGHGVXUYH\V
Data extracted by, and data cross-checked by
The name of people who will extract and cross-check the data.
Table 3. Data extraction form
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FXODWHG VSHFL¿FDOO\ IRU WKH FRXQWU\)LIWK GDWD VRXUFHVPD\EH
heterogeneous, which will be managed by statistical methods. 
Finally, despite our extensive data pursuing, we have three types 
of scarcity; geographical scarcity; temporal scarcity; and old-age 
scarcity. 
Results of this study help us to model a number of interven-
WLRQ VFHQDULRV )RU H[DPSOH LI ZH ¿QG EXUGHQ RI GLVHDVHV DW-
tributable to nutritional risk factors among Iranians, promoting 
public awareness about diet through mass media, and a general 
shift toward the Guidelines diet should be implemented. In spe-
FL¿FFDVHVVXFKDVUHGXFLQJEORRGSUHVVXUHVSHFL¿FHIIRUWVZLOO
be made to reduce the use of salt as an additive in manufactured 
foods. Further potential examples include some interventions in 
our oil industry to reduce the amount of trans fatty acids in hydro-
genated vegetable oils, and restrictions on marketing of foods and 
beverages high in salt, fats and sugar. Findings from the burden 
of diseases attributable to physical inactivity or tobacco smoking 
will result in formulating policy approaches to encourage physi-
cal activity, or to reduce smoking among the Iranian population. 
Protecting people from tobacco and banning smoking in public 
places, warning about the dangers of tobacco use, regular and 
VLJQL¿FDQW LQFUHDVHV LQ WKHSULFHRIFLJDUHWWHVDQGUDLVLQJWD[HV
on tobacco are some potential interventions to decrease levels of 
smoking in the population.
In addition to these low-cost solutions, which work everywhere 
to reduce the hazards of lifestyle risk factors on NCDs, there is 
strong evidence, though currently a shortage of cost-effective-
ness research, for the following interventions: healthy nutrition 
environments in schools, nutrition information and counsel-
ing in health care, national physical activity guidelines, school-
based physical activity programmes for children, workplace 
programmes for physical activity and healthy diets, community 
programmes for physical activity and healthy diets, and designing 
the built environment to promote physical activity. Mass media 
can be used to educate people about healthy nutrition, food labels, 
and healthy snacks. To encourage people to undertake physical 
activity, the government can announce automobile-free days and 
built bicycle lanes in cities. Smoking can be banned in workplaces 
or public places and smoking cessation clinics can be organized 
by the government to decrease rates of smoking.
Little is known about distributions and quantitative effects of 
VSHFL¿FOLIHVW\OHULVNIDFWRUVRQFKURQLFGLVHDVHVLQGLIIHUHQWUH-
gions of Iran. The current study will systematically assess and 
compile nationally representative data on exposure distributions 
A: Sampling Quality
(I) Sampling method
1. Multi-level clustering random sampling
2. One-level clustering random sampling
3. Simple random sampling
4. Others
(II) Sample size
0. Less than 250 
1. 250 to 500
2. 500 to 1000
3. More than 1000
(III) Response rate
0. Less than 59 %
2. 60 to 74 %
4. 75 to 89 %
6. More than 90 %
B: Measurement Quality (for nutrition studies only)
(IV) Diet Assessment Method
0XOWLSOHVKRUWWHUPXSWRZHHNGLHWUHFDOOVUHFRUGVZLWKRUZLWKRXWFRUUHFWLRQIRUZLWKLQSHUVRQYDULDWLRQ
2. Food frequency questionnaires
3. Single short-term diet recalls/ records
4. Household availability/ budget survey
(V) Data collection techniques
5. Self-administered questionnaire
6. Telephone interview
7. Personal interview
(VI) Food record has been
1. Non-Weighting
2. Weighting
(VII) Validation (for FFQ)
1. Yes
2. No
Table 4. 5DQNLQJVFDOHVWRDVVHVVWKHTXDOLW\RILGHQWL¿HGVXUYH\V
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and heterogeneity of major lifestyle risk factors across regions 
DQGDPRQJVH[DQGDJHVSHFL¿FJURXSV6XFKQDWLRQDODQGVXE
national assessment is necessary for priority setting and policy 
PDNLQJLQGLIIHUHQWUHJLRQVRIRXUFRXQWU\DOORZLQJLGHQWL¿FDWLRQ
and targeting of the dietary factors, as well as physical activity 
and tobacco smoking behaviors, with greatest impact on CVD, 
diabetes and cancer events and deaths. This study is also critical to 
understand reasons for and thus to reduce health disparities across 
different regions of Iran. 
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Nutrition
yPubMed
|Fruit 
(“fruit” [MeSH] OR “fruit” [tiab] OR “fruits” [tiab])
|Fruit juice
(“fruit juice” [tiab] OR “fruit juices” [tiab] OR “juice” [tiab] OR “juices” [tiab])
|Vegetable
(“Vegetables” [MeSH] OR “Vegetables” [tiab] OR “Vegetable” [tiab])
|Whole grain
(“Whole grains” [tiab] OR “Whole grain” [tiab])
|Beans and legumes
(“Bean” [tiab] OR “Beans” [tiab] OR “legumes” [tiab] OR “legume” [tiab])
|Nuts and seeds
(“Nuts” [MeSH] OR “Nuts” [tiab] OR “Nut” [tiab] OR “Seeds” [MeSH] OR “Seeds” [tiab] OR “Seed” [tiab])
|Meat
(“meat” [Mesh] OR “meat” [tiab] OR “meats” [tiab])
|Milk and dairy
(“Milk” [MeSH] OR “Milk” [tiab]OR “Yogurt” [MeSH] OR “Yogurt” [tiab] OR “Yoghurt” [tiab] OR “Cheese” [MeSH] OR “Cheese” [tiab] OR “Cheeses” 
[tiab] OR “Ice Cream” [MeSH] OR “Ice Cream” [tiab] OR “Ice Creams” [tiab] OR “Cream” [tiab] OR “Dairy” [tiab] OR “Dairy Products” [MeSH] OR 
“Dairy Products” [tiab] OR “Dairy Product” [tiab] OR “Cultured Milk Products” [MeSH] OR “Cultured Milk Products” [tiab] OR “Cultured Milk Product” 
[tiab] OR “Milk Product” [tiab] OR “Milk Products” [tiab])
|Sweetened beverages
(“beverages” [MeSH] OR “beverages” [tiab] OR “beverage” [tiab])
|Fatty acids
"Fatty Acids, Omega-6"[MeSH] OR "Fatty Acids, Omega-3"[MeSH] OR "Fatty Acids, Unsaturated"[MeSH] OR "Fatty Acids, Monounsaturated"[ 
MeSH] OR "Trans Fatty Acids"[MeSH] OR "monounsaturated"[tiab] OR "mono-unsaturated"[tiab] OR "MUFA"[tiab] OR "unsaturated"[tiab] OR 
"polyunsaturated"[tiab] OR "PUFA"[tiab] OR "saturated"[tiab] OR "SFA"[tiab] OR "trans-unsaturated"[tiab] OR "trans-fatty"[tiab] OR "trans fatty"[tiab] 
OR "trans unsaturated"[tiab] OR "trans fat"[tiab] OR "TFA"[tiab] OR "omega-6"[tiab] OR "omega-3"[tiab] OR "n-6"[tiab] OR "n-3"[tiab] OR “alpha-
linolenic”[tiab] OR "oleic"[tiab] OR "linoleic"[tiab]
|Fiber
³'LHWDU\)LEHU´>0H6+@25³'LHWDU\)LEHU´>WLDE@25³'LHWDU\¿EHUV´>WLDE@25³'LHWDU\¿EUH´>WLDE@25³'LHWDU\¿EUHV´>WLDE@25³)LEHULQWDNH´>WLDE@
|Cholesterol
(“Cholesterol, Dietary” [MeSH] OR “Dietary cholesterol” [tiab] OR “cholesterol intake” [tiab])
|Sodium
(“Sodium, Dietary” [MeSH] OR “Dietary Sodium” [tiab] OR “sodium intake” [tiab])
Appendix: Keywords used for search in International and National databases
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|Calcium
(“Calcium, Dietary” [MeSH] OR “Dietary Calcium” [tiab] OR “calcium intake” [tiab])
|Fish
(“Fishes” [MeSH], OR “Fish” [tiab] OR “Fishes” [tiab] OR “Fish products” [MeSH] OR “Fish products” [tiab] OR “Fish product”[tiab] OR “Seafood” 
[MeSH] OR “Seafood” [tiab] OR “Sea food” [tiab] OR “Sea foods” [tiab] OR “Seafoods” [tiab] OR “Marine” [tiab])
|Processed meat
(“Meat products” [MeSH] OR “Meat products” [tiab], OR “Meat product” [tiab] OR “Poultry products” [MeSH], OR “Poultry products” [tiab] OR “Poultry 
SURGXFW´>WLDE@25³3URFHVVHGPHDW´>WLDE@25³3URFHVVHGSRXOWU\´>WLDE@25³3URFHVVHG¿VK´>WLDE@25³6PRNHGPHDW´>WLDE@25³6PRNHG¿VK´>WLDE@25
³6DOWHGPHDW´>WLDE@25³6DOWHG¿VK´>WLDE@
yISI
|Fruit 
(“fruit” OR “fruits”)
|Fruit juice
(“fruit juice” OR “fruit juices”OR “juice” OR “juices”)
|Vegetable
(“Vegetable” OR “Vegetables”)
|Whole grain
(“Whole grains” OR “Whole grain”)
|Beans and legumes
(“Bean” OR “Beans” OR “legumes” OR “legume”)
|Nuts and seeds
(“Nuts” OR “Nut” OR “Seeds”OR “Seed”)
|Meat
(“meat” OR “meats”)
|Milk and dairy
(“Milk” OR “Yogurt” OR “Yoghurt” OR “Cheese” OR “Cheeses” OR “Ice Cream” OR “Ice Creams” OR “Cream” OR “Dairy” OR “Dairy Products” OR 
“Dairy Product” OR “Cultured Milk Products” OR “Cultured Milk Product” OR “Milk Product” OR “Milk Products”)
|Sweetened beverages
(“beverages” OR “beverage”)
|Fatty acids
"Fatty Acids, Omega-6" OR "Fatty Acids, Omega-3" OR "Fatty Acids, Unsaturated" OR "Fatty Acids, Monounsaturated" OR "Trans Fatty Acids" OR 
"monounsaturated" OR "mono-unsaturated" OR "MUFA" OR "unsaturated" OR "polyunsaturated" OR "PUFA" OR "saturated" OR "SFA" OR "trans-
unsaturated" OR "trans-fatty" OR "trans fatty" OR "trans unsaturated" OR "trans fat" OR "TFA" OR "n-6" OR "n-3" OR “alpha-linolenic” OR "oleic" OR 
"linoleic"
|Fiber
³'LHWDU\)LEHU´25³'LHWDU\¿EHUV´25³'LHWDU\¿EUH´25³'LHWDU\¿EUHV´25³)LEHULQWDNH´
|Cholesterol
(“Dietary cholesterol” OR “cholesterol intake”)
|Sodium
(“Dietary Sodium” OR “sodium intake”)
|Calcium
(“Dietary Calcium”OR “calcium intake”)
|Fish
(“Fishes”, OR “Fish” OR “Fish products” OR “Fish products” OR “Seafood” OR “Seafood” OR “Seafoods” OR “Sea foods” OR “Marine”)
|Processed meat
³0HDWSURGXFWV´25³0HDWSURGXFW´25³3RXOWU\SURGXFWV´25³3RXOWU\SURGXFW´25³3URFHVVHGPHDW´25³3URFHVVHGSRXOWU\´25³3URFHVVHG¿VK´25
³6PRNHGPHDW´25³6PRNHG¿VK´25³6DOWHGPHDW´25³6DOWHG¿VK´
yScopus
|Fruit 
(“fruit” OR “fruits”)
|Fruit juice
(“fruit juice” OR “fruit juices”OR “juice” OR “juices”)
|Vegetable
(“Vegetable” OR “Vegetables”)
|Whole grain
(“Whole grains” OR “Whole grain”)
|Beans and legumes
(“Bean” OR “Beans” OR “legumes” OR “legume”)
|Nuts and seeds
(“Nuts” OR “Nut” OR “Seeds”OR “Seed”)
|Meat
(“meat” OR “meats”)
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|Milk and dairy
(“Milk” OR “Yogurt” OR “Yoghurt” OR “Cheese” OR “Cheeses” OR “Ice Cream” OR “Ice Creams” OR “Cream” OR “Dairy” OR “Dairy Products” OR 
“Dairy Product” OR “Cultured Milk Products” OR “Cultured Milk Product” OR “Milk Product” OR “Milk Products”)
|Sweetened beverages
(“beverages” OR “beverage”)
|Fatty acids
"Fatty Acids, Omega-6" OR "Fatty Acids, Omega-3" OR "Fatty Acids, Unsaturated" OR "Fatty Acids, Monounsaturated" OR "Trans Fatty Acids" OR 
"monounsaturated" OR "mono-unsaturated" OR "MUFA" OR "unsaturated" OR "polyunsaturated" OR "PUFA" OR "saturated" OR "SFA" OR "trans-
unsaturated" OR "trans-fatty"OR "trans fatty" OR "trans unsaturated" OR "trans fat" OR "TFA" OR "n-6" OR "n-3" OR “alpha-linolenic” OR "oleic" OR 
"linoleic"
“omega 6 fatty acid” OR “omega 6 fatty acids” OR “n 6 fatty acid” OR “omega 6 polyunsaturated fatty acid” OR “omega 3 fatty acid” OR “omega 3 fatty 
acids” OR “n 3 fatty acid” OR “n 3 polyunsaturated fatty acid” OR “omega 3” OR “omega 3 polyunsaturated fatty acid” OR “unsaturated fatty acid” OR 
“unsaturated fatty acids” OR “unsaturated fat” OR “UFA” OR “unsaturated lipid” OR “monounsaturated fatty acid” OR “monounsaturated fatty acids” OR 
“trans fatty acid” OR “trans unsaturated” OR “trans fatty acids” OR “trans unsaturated fatty acid” OR “unsaturated trans fatty acid”
|Fiber
³'LHWDU\)LEHU´25³'LHWDU\¿EHUV´25³'LHWDU\¿EUH´25³'LHWDU\¿EUHV´25³)LEHULQWDNH´25³'LHW¿EHU´
|Cholesterol
(“Dietary cholesterol” OR “cholesterol intake” OR “cholesterol feeding”)
|Sodium
(“Dietary Sodium” OR “sodium intake”)
|Calcium
(“Dietary Calcium” OR “calcium intake” OR “Calcium feeding”)
|Fish
(“Fishes”, OR “Fish” OR “Fish products” OR “Fish products” OR “Seafood” OR “Seafood” OR “Sea food” OR “Sea foods” OR “Seafoods” OR “Marine”)
|Processed meat
³0HDWSURGXFWV´25³0HDWSURGXFW´25³3RXOWU\SURGXFWV´25³3RXOWU\SURGXFW´25³3URFHVVHGPHDW´25³3URFHVVHGSRXOWU\´25³3URFHVVHG¿VK´25
³6PRNHGPHDW´25³6PRNHG¿VK´25³6DOWHGPHDW´25³6DOWHG¿VK´25³6DXVDJH´
yIranMedex, SID and Irandoc
|Fruit 
³0LYHK´³0LYHKD´³0LYHMDW´³0RUDNDEDW´³6HL¿MDW´
|Fruit juice
“Ab Miveh”, “Ab Porteghal”, “ Ab Anar”, “Ab Albalou”
|Vegetable
“Sabzi”, “Sabziha”, “Sabzijat”
|Whole grain
“Ghalat-e Kamel”, “Sabus Dar”, “Nan-e Sangak”, “Nan-e Jo”
|Beans and legumes
“Hoboubat”, “Loubia”, “Adas”, “Nokhod”, “Mash”, “Lapeh”, “Soya”
|Nuts and seeds
“Ajil”, “Khoshkbar”, “Gerdou”, “Fandogh”, “Pesteh”, “Badam”, “Tokhmeh”, “Konjed”, “Shahdaneh”
|Meat
“Gousht”
|Milk and dairy
“Labaniat”, “Labani”, “Shir”, “Mast”, “Dough”, “Kashk”, “Panir”, “Bastani”, “Khameh”
|Sweetened beverages
“Noshidani”, “Noushabeh”, “Souda”
|Fatty acids
“Charb-e Terans”, “Roghan-e Hidrojeneh”, “Roghan-e Jamed”, “Roghan-e Nimeh Jamed”, “Kareh-ye Giahi”, “Charb-e Omega”, “Charb-e N”, “Linoleik”, 
“Arashidonik”, “Charb-e Daryaei”, “Ikozanoik”, “Dokoza Hegzanoik”, “Ikoza Pantanoik”, “Linolenik”, “Roghan-e Mahi”, “Charb-e Eshba”, “Botirik”, 
“Lorik”, “Miristik”, “Palmetik”, “Palmitat”, “Estearik”, “Estearat”, “Lorat”, “Miristat”, “Ikozanoik”, “Dekanoik”, “Arashidik”
|Fiber
“Fibr-e Ghaza”, “Fibr-e Rejim”, “Sabus”, “Daryaft-e Fibr”, “Masraf-e Fibr”
|Cholesterol
“Kolestrol-e Rejim”, “Daryaft-e Kolestrol”, “Kolestrol-e Daryafti”, “Kolestrol-e Ghaza”
|Sodium
“Sodiom-e Rejim”, “Sodiom-e Ghaza”, “Sodiom Koloraid”, “Sodiom Kolorid”, “Daryaft-e Namak”, “Masraf-e Namak”, “Namak-e Ghaza” 
|Calcium
“Kalsiom-e Rejim”, “Kalsiom-e Ghaza”, “Daryaft-e Kalsiom”, “Kalsiom-e Daryafti”
|Fish
“Mahi”, “Meigou”
|Processed meat
“Gousht-e Faravari”, “Kalbas”, “Sosis”, “Hot Dog”, “Mahi Doudi”, “Namak Soud”
Physical Activity
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yPubMed
(“Motor Activity”[Mesh] OR “Motor Activity”[tiab]OR“Physical Activity”[tiab]OR“ Inactivity”[tiab]“Exercise”[Mesh] OR “Exercise”[tiab] OR “Muscle 
Stretching Exercises”[Mesh] OR “Muscle Stretching Exercises”[tiab] OR“Muscle Stretching Exercise”[tiab] OR“Plyometric Exercise”[Mesh] OR 
“Plyometric Exercise”[tiab] OR“Plyometric Exercise”[tiab] OR“Resistance Training”[Mesh] OR “Resistance Training”[tiab] OR“Resistance Trainings”[tiab] 
OR “Running”[Mesh] OR “Running”[tiab]  OR “Jogging”[Mesh] OR “Jogging”[tiab] OR “Swimming”[Mesh] OR “Swimming”[tiab] OR “Diving” [Mesh] 
OR “Diving” [tiab] OR “Walking” [Mesh] OR “Walking” [tiab] OR “Life Style” [Mesh] OR “Life Style” [tiab] OR “Life Styles” [tiab] OR “Lifestyle” 
[tiab] OR “Lifestyles” [tiab] “Sedentary Lifestyle”[Mesh] OR “Sedentary Lifestyle”[tiab] OR “television viewing”[tiab]  OR “computer use” [tiab] OR 
“screen time” [tiab] OR “sedentary activities” [tiab] OR “screen-based behavior” [tiab] OR “television watching” [tiab] OR “sedentary pursuits” [tiab] 
OR “TV/computer time” [tiab] OR “screen-time” [tiab] OR “Risk Reduction Behavior”[Mesh] OR “Risk Reduction Behavior”[tiab]“Sports”[Mesh] OR 
“Sports”[tiab] OR “Athletic Performance”[Mesh] OR “Athletic Performance”[tiab] OR “Physical Endurance”[Mesh] OR “Physical Endurance”[tiab] OR 
“Baseball”[Mesh] OR “Baseball”[tiab] OR “Basketball”[Mesh] “Basketball”[tiab] OR “Bicycling”[Mesh] OR “Bicycling”[tiab] OR “Boxing”[Mesh] 
OR “Boxing”[tiab] OR “Football”[Mesh] OR “Football”[tiab] OR “Golf”[Mesh] OR “Golf”[tiab] OR “Gymnastics”[Mesh] OR “Gymnastics”[tiab] 
OR “Hockey”[Mesh] OR “Hockey”[tiab] OR “Martial Arts”[Mesh] OR “Martial Arts”[tiab] OR “Mountaineering”[Mesh] “Mountaineering”[tiab] OR 
“Skating”[Mesh] OR “Skating”[tiab] OR “Snow Sports”[Mesh] OR “Snow Sports”[tiab] OR“Soccer”[Mesh] OR “Soccer”[tiab]OR “Swimming”[Mesh] OR 
“Swimming”[tiab] OR “Track and Field”[Mesh] OR “Track and Field”[tiab]“Skiing”[Mesh] OR “Skiing”[tiab] OR “Diving”[Mesh] OR “Diving”[tiab] OR 
“Volleyball”[Mesh] OR “Volleyball”[tiab] OR “Weight Lifting”[Mesh] OR “Weight Lifting”[tiab] OR “Wrestling”[Mesh] OR “Wrestling”[tiab] OR “leisure 
activity” [tiab] OR “vigorous activity” [tiab])
yISI
“Motor Activity”OR”Physical Activity” OR “ Inactivity” OR “Exercise” OR “Muscle Stretching Exercises” OR “Muscle Stretching 
Exercise”OR”Plyometric Exercise”  OR “Plyometric Exercise” OR “Resistance Training” OR  “Resistance Trainings” OR “Running” OR “Jogging”OR 
“Swimming” OR “Diving” OR “Walking” OR “Life Style” OR “Life Styles” OR “Lifestyle” OR “Lifestyles” OR “Sedentary Lifestyle” OR “Risk Reduction 
Behavior” “Sedentary Lifestyle” OR “television viewing”  OR “computer use”  OR “screen time” OR “sedentary activities”  OR “screen-based behavior” 
OR “television watching” OR “sedentary pursuits” OR “TV/computer time” OR “screen-time” OR “Sports”OR “Athletic Performance”OR “Physical 
Endurance”OR “Baseball” OR “Basketball”OR “Bicycling”OR “Boxing”OR “Football”OR “Golf” OR “Gymnastics” OR “Hockey” OR “Martial Arts” OR 
“Mountaineering”OR “Skating” OR “Snow Sports” OR”Soccer” OR “Swimming” OR “Track and Field” OR “Skiing” OR “Diving” OR “Volleyball” OR 
“Weight Lifting” OR “Wrestling” OR “leisure activity” OR “vigorous activity”
yScopus
“Motor Activity”OR”Physical Activity” OR “ Inactivity” OR “Exercise” OR “Muscle Stretching Exercises” OR “Muscle Stretching 
Exercise”OR”Plyometric Exercise”  OR “Plyometric Exercise” OR “Resistance Training” OR  “Resistance Trainings” OR “Running” OR “Jogging”OR 
“Swimming” OR “Diving” OR “Walking” OR “Life Style” OR “Life Styles” OR “Lifestyle” OR “Lifestyles” OR “Sedentary Lifestyle” OR “Risk Reduction 
Behavior” “Sedentary Lifestyle” OR “television viewing”  OR “computer use”  OR “screen time” OR “sedentary activities”  OR “screen-based behavior” 
OR “television watching” OR “sedentary pursuits” OR “TV/computer time” OR “screen-time” OR “Sports”OR “Athletic Performance”OR “Physical 
Endurance”OR “Baseball” OR “Basketball”OR “Bicycling”OR “Boxing”OR “Football”OR “Golf” OR “Gymnastics” OR “Hockey” OR “Martial Arts” OR 
“Mountaineering”OR “Skating” OR “Snow Sports” OR”Soccer” OR “Swimming” OR “Track and Field” OR “Skiing” OR “Diving” OR “Volleyball” OR 
“Weight Lifting” OR “Wrestling” OR “leisure activity” OR “vigorous activity”
yIranMedex, SID and Irandoc
“Faaliyat-e Badani”, “Adam-e Faalyiat-e Badani”, “Varzesh”, “Tamrin”, “Sargarmi”, “Oghat-e Faraghat”, “Tafrih”, “Tamasha-ye Televizun”
Smoking
yPubMed
 (“Smoking”[Mesh] OR “Smoke”[Mesh]OR “Tobacco Use Disorder”[Mesh] OR “Tobacco Smoke Pollution”[Mesh])
yISI
6PRNLQJ25³FLJDUHWWHVPRNLQJ´25³WREDFFRVPRNLQJ´256PRN25³7REDFFR8VH'LVRUGHU´25³QLFRWLQHXVHGLVRUGHU´25³WREDFFRGHSHQGHQFH´
OR “nicotine dependence” OR “Tobacco Smoke Pollution” OR “passive smoking” OR “secondhand smoking” OR “involuntary smoking”)
yScopus
6PRNLQJ25³FLJDUHWWHVPRNLQJ´25³WREDFFRVPRNLQJ´256PRN25³7REDFFR8VH'LVRUGHU´25³QLFRWLQHXVHGLVRUGHU´25³WREDFFRGHSHQGHQFH´
OR “nicotine dependence” OR “Tobacco Smoke Pollution” OR “passive smoking” OR “secondhand smoking” OR “involuntary smoking” OR “tobacco 
constituent” OR “reverse smoking”)
yIranMedex, SID and Irandoc
“Sigar”, “Dokhaniat”, “Tanbakou”, “Nikotin”, “Masraf-e Sigar”, “Sigar Keshidan”
